Undisclosed · Biotech
Alcolase raises €1.5m to advance enzyme technology and market-entry work
Ada Ventures, Delphinus Venture Capital, Antler and other backers fund research and early commercial preparation.
Financing context
The financing supports an in vivo study, technology development, intellectual-property work and initial partnerships. Alcolase is preparing for Singapore before South Korea.
A UK subsidiary will develop broader therapeutic delivery applications, with Ada supporting access to the UK life-sciences ecosystem. Ada venture partner Alasdair Thong is joining the board. These are development and commercialization steps; the company has not reported an approved product.
Funding history
Undisclosed · This round€1.5M